WBA Logo

Walgreens Boots Alliance, Inc. (WBA) 

NASDAQ
Market Cap
$7.8B
Sector
Healthcare
Industry
Medical—Pharmaceuticals
Rank in Sector
179 of 971
Rank in Industry
1 of 6

Largest Insider Buys in Sector

WBA Stock Price History Chart

WBA Stock Performance

About Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Insider Activity of Walgreens Boots Alliance, Inc.

Over the last 12 months, insiders at Walgreens Boots Alliance, Inc. have bought $512,643 and sold $350,567 worth of Walgreens Boots Alliance, Inc. stock.

On average, over the past 5 years, insiders at Walgreens Boots Alliance, Inc. have bought $499,568 and sold $398,000 worth of stock each year.

Highest buying activity among insiders over the last 12 months: WENTWORTH TIMOTHY C (Chief Executive Officer) — $484,440. JARRETT VALERIE B (director) — $299,978. Mahajan Manmohan (EVP and Global CFO) — $116,280.

The last purchase of 3,000 shares for transaction amount of $54,150 was made by Bhandari Inderpal S (director) on 2024‑04‑11.

List of Insider Buy and Sell Transactions, Walgreens Boots Alliance, Inc.

2024-04-11Purchasedirector
3,000
0.0003%
$18.05$54,150-39.80%
2024-04-02PurchaseEVP and Global CFO
6,000
0.0007%
$19.38$116,280-39.64%
2024-01-29Purchasedirector
4,456
0.0005%
$22.44$99,993-29.70%
2024-01-16Saledirector
15,209
0.0018%
$23.05$350,567-30.30%
2024-01-05PurchaseChief Executive Officer
10,000
0.0011%
$24.22$242,220-34.96%
2023-11-10SaleSVP, Chief Pharmacy Officer
1,000
0.0001%
$20.45$20,450-13.14%
2023-06-30PurchaseEVP, Pres. U.S. Healthcare
5,172
0.0006%
$28.42$146,984-23.94%
2023-03-29PurchaseCEO
10,000
0.0012%
$33.95$339,510-28.17%
2022-11-18SaleEVP, Chief Medical Officer
10,303
0.0012%
$40.19$414,108-18.41%
2022-11-17Saledirector
16,570
0.0019%
$39.89$660,928-19.14%
2021-11-19Saledirector
2,725
0.0003%
$47.16$128,497-6.94%
2020-11-11SaleEVP, Global CAO and GC
10,000
0.0012%
$41.55$415,450+21.52%
2019-11-05SaleEVP, Global CAO and GC
468,710
0.0543%
$63.16$29.6M-28.46%
2019-08-15SaleEVP, Global CAO and GC
246,992
0.0272%
$50.06$12.36M+3.23%
2019-08-14SaleEVP, Global CAO and GC
183,654
0.0202%
$51.03$9.37M+0.91%
2019-05-09SaleEVP, Global CAO and GC
40,000
0.0044%
$53.05$2.12M+0.56%
2019-04-03PurchaseCo-Chief Operating Officer
36,000
0.0039%
$54.56$1.96M-0.93%
2018-11-20Saledirector
14,100
0.0015%
$78.81$1.11M-29.63%
2018-11-01Saledirector
5,472
0.0006%
$79.48$434,915-29.34%
2018-11-01SaleSVP, Global Controller and CAO
15,705
0.0017%
$79.79$1.25M-29.34%

Insider Historical Profitability

<0.0001%
WENTWORTH TIMOTHY CChief Executive Officer
585122
0.0677%
$9.0210
Mahajan ManmohanEVP and Global CFO
166969
0.0193%
$9.0210
JARRETT VALERIE Bdirector
4456
0.0005%
$9.0210
Bhandari Inderpal Sdirector
3000
0.0003%
$9.0210
SCHLICHTING NANCY Mdirector
0
0%
$9.0204
Pessina StefanoExecutive Vice Chairman, CEO
144788821
16.746%
$9.0231+4.43%
Rosenstein Barrydirector
4579100
0.5296%
$9.0206
Barra OrnellaCo-Chief Operating Officer
1718000
0.1987%
$9.0231+1.29%
Gourlay Alexander W.EVP and President of Walgreens
734389
0.0849%
$9.0201
Fairweather George RolloEVP and Global CFO
513563
0.0594%
$9.0201
BREWER ROSALIND GCEO
369945
0.0428%
$9.0210<0.0001%
Gates Richard P.SVP, Chief Pharmacy Officer
73929
0.0086%
$9.0201
DRISCOLL JOHN PATRICKEVP, Pres. U.S. Healthcare
59050
0.0068%
$9.0210<0.0001%
Wilson-Thompson KathleenEVP and Global Chief HRO
55676
0.0064%
$9.0208
Lederer John Anthonydirector
50000
0.0058%
$9.0240<0.0001%
SABATINO THOMAS J JREVP, Global CLO and CAO
44536
0.0052%
$9.0201
Pagni Marco Patrick AnthonyEVP, Global CAO and GC
34700
0.004%
$9.0205
Ban Kevin M.EVP, Chief Medical Officer
27916
0.0032%
$9.0201
FOOTE WILLIAM Cdirector
8207
0.0009%
$9.02011
SCHAEFFER LEONARD Ddirector
1512
0.0002%
$9.0210<0.0001%
GRAHAM GINGER Ldirector
2150
0.0002%
$9.0210+4.1%
Babiak Janice M.director
1200
0.0001%
$9.0220+2.2%
Murphy KenEVP, Chief Commercial Officer
653
0.0001%
$9.0201
Scardino Kimberly RSVP, Global Controller and CAO
0
0%
$9.0201

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$1.78B9.5382.26M-1.06%-$19.1M0.03
BlackRock$1.48B7.8968.13M+3.4%+$48.58M0.03
State Street$785.04M4.1936.19M-33.2%-$390.11M0.03
Capital World Investors$630.33M3.3729.06M+57.52%+$230.18M0.11
Geode Capital Management$409.49M2.1918.88M+13.99%+$50.25M0.04
Invesco$375.39M2.0117.31M-9.16%-$37.85M0.08
Morgan Stanley$273.32M1.4612.6M-25.69%-$94.47M0.02
Camber Capital Management Lp$169.18M0.97.8M+11.43%+$17.35M5.96
Northern Trust$159.13M0.857.34M-0.48%-$770,190.210.03
Legal & General$157.13M0.847.24M-1.53%-$2.43M0.04
Charles Schwab$152.59M0.827.03M+7.9%+$11.17M0.03
JPMorgan Chase$135.11M0.726.23M+74.33%+$57.61M0.01
Goldman Sachs$126.01M0.675.81M+25.53%+$25.63M0.02
BNY Mellon$119.28M0.645.5M-7.6%-$9.81M0.02
Ubs Asset Management Americas Inc$116.27M0.625.36M-3.73%-$4.5M0.04
Sessa Capital Master L P$103.43M0.554.77M+26.34%+$21.56M4.03
Allianz Asset Management Gmbh$99.1M0.534.57M+16.61%+$14.12M0.17
LSV Asset Management$88.09M0.474.06M-9.99%-$9.77M0.18
Barclays$81.16M0.433.74M+6.34%+$4.84M0.04
Dimensional Fund Advisors$76.04M0.413.51M+4.8%+$3.48M0.02
Amundi$53.51M0.353.04M+63.91%+$20.86M0.02
Susquehanna International Group$65.71M0.353.03M+403.34%+$52.66M0.07
TSW (Thompson, Siegel & Walmsley LLC)$65.69M0.353.03MNew+$65.68M1.01
UBS$64.31M0.342.97M-17.82%-$13.94M0.02
Royal Bank of Canada$61.2M0.332.82M+5.03%+$2.93M0.02
Schroder Investment Management Group$60.28M0.322.78M+23.54%+$11.49M0.07
Man Group Plc$56.11M0.32.59M+58.3%+$20.66M0.14
Fidelity Investments$55.86M0.32.58M+114.08%+$29.76M<0.01
Sumitomo Mitsui Trust Holdings$55.57M0.32.56M-16.74%-$11.17M0.04
Millennium Management LLC$52.47M0.282.42M+71.11%+$21.81M0.03
Deutsche Bank$51.4M0.282.37M+8.29%+$3.94M0.02
Swiss National Bank$47.61M0.252.2M-4.4%-$2.19M0.03
First Trust$47.25M0.252.18M-33.98%-$24.32M0.05
Balyasny Asset Management Llc$46.59M0.252.15M+18.16%+$7.16M0.13
Ameriprise Financial$41.78M0.221.93M+91.29%+$19.94M0.01
Nuveen$40.01M0.211.84M-5.45%-$2.31M0.01
Ariel Investments$39.91M0.211.84M+25.29%+$8.06M0.39
Renaissance Technologies$39.68M0.211.83MNew+$39.68M0.06
Citigroup$39.49M0.211.82M+46.57%+$12.55M0.03
Grantham Mayo Van Otterloo & Co LLC$39.13M0.211.8M-3.4%-$1.38M0.12
Bank of America$38.73M0.211.79M+40.71%+$11.2M<0.01
Wells Fargo$35.99M0.191.66M-21.44%-$9.82M0.01
Bank of Montreal$36.01M0.191.66M-7.54%-$2.93M0.01
National Pension Service$34.49M0.181.59M+2.47%+$831,030.650.04
Hrt Financial Llc$32.74M0.181.51M+3,419%+$31.81M0.21
De Depot Et Placement Du Quebec Caisse$32.54M0.171.5M+349.29%+$25.29M0.08
Citadel Advisors LLC$32.41M0.171.49M+303.41%+$24.38M0.02
HSBC$31.29M0.171.44M-16.68%-$6.27M0.02
RhumbLine Advisers$30.16M0.161.39M+0.36%+$107,083.160.03
Integral Health Asset Management Llc$28.2M0.151.3M+18.18%+$4.34M2.83
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.